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Abstract
Type 2 immune responses are essential in protection against intestinal helminth infections. In this study we show that IL-22,
a cytokine important in defence against bacterial infections in the intestinal tract, is also a critical mediator of anti-helminth
immunity. After infection with Nippostrongylus brasiliensis, a rodent hookworm, IL-22-deficient mice showed impaired worm
expulsion despite normal levels of type 2 cytokine production. The impaired worm expulsion correlated with reduced
goblet cell hyperplasia and reduced expression of goblet cell markers. We further confirmed our findings in a second
nematode model, the murine whipworm Trichuris muris. T.muris infected IL-22-deficient mice had a similar phenotype to
that seen in N.brasiliensis infection, with impaired worm expulsion and reduced goblet cell hyperplasia. Ex vivo and in vitro
analysis demonstrated that IL-22 is able to directly induce the expression of several goblet cell markers, including mucins.
Taken together, our findings reveal that IL-22 plays an important role in goblet cell activation, and thus, a key role in anti-
helminth immunity.
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Introduction
Type 2 immune responses are essential in protection against
intestinal helminth infections, including the rodent hookworm
Nippostrongylus brasiliensis (Nb) [1]. Type 2 immunity involves the
recruitment of effector cells such as eosinophils, mast cells and
production of IgE antibodies [2] and it is well established that the
activation of IL-4- and IL-13-producing CD4+ T helper 2 cells is
central in the development of a successful anti-parasite response.
One of the key components in the expulsion of intestinal helminths
is secretion of mucus by goblet cells [2]. Intestinal goblet cells are
found interspersed within the epithelial monolayer and are
differentiated from epithelial progenitor cells. Goblet cells produce
a number of effector molecules including a range of mucins and
antimicrobial proteins, including trefoil factors and resistin-like
molecules, which enable these to play a key part in innate defense
mechanisms in the gut, against both bacterial and helminth
infections [2,3].
IL-22 is a member of the IL-10 cytokine family and is produced
by a wide variety of innate and adaptive immune cells including
CD4+ T cells, most notably Th17 and Th22 cells, CD8+ T cells,
natural killer (NK) cells, lymphoid tissue inducer (LTi) cells and
other group 3 innate lymphoid cells (ILCs) [4]. The heterodimeric
receptor for IL-22, consisting of the IL-22R and the IL-10R2
chain, is exclusively expressed on non-hematopoietic cells, such as
intestinal epithelial cells, and its signaling is mediated via Stat3
[5,6,7,8,9]. IL-22 has been shown to directly mediate epithelial
defence mechanisms through the induction of IL-6, IL-8 and
various antimicrobial peptides [6,10,11,12,13]. Furthermore, a
protective function of IL-22 has been demonstrated in some colitis
models and a model of Concanavalin A induced liver damage
[14,15,16,17]. Therefore it appears that the function of IL-22 is to
strengthen epithelial barriers, mediate repair and wound healing
mechanisms as well as participate in epithelial defence. Interest-
ingly, IL-22 has been shown to be upregulated within the human
gastrointestinal tract following infections with the whipworm
Trichuris trichiuria and the hookworm Necator americanus [18,19], but
no studies have as yet demonstrated a role for IL-22 in intestinal
helminth infections and the associated type 2 response.
To clarify the role for IL-22 in the defence against intestinal
helminth infection, we infected wild-type (WT) and IL-22-deficient
mice with Nippostrongylus brasiliensis, a rodent nematode with a life
cycle resembling that of human hookworm. Our data show that
IL-22-deficient mice have reduced worm clearance, despite strong
induction of IL-4, IL-5 and IL-13 in the mesenteric lymph nodes
and mucosal tissue. Despite this intact type 2 cytokine induction
IL-22-deficient mice showed a defective goblet cell response and in
vitro and ex vivo analyses revealed that IL-22 can directly regulate
the expression of several goblet cell markers. Taken together, our
data suggest that IL-22 plays a key role in driving intestinal goblet
cell responses in vivo and thus acts as an important mediator of
intestinal worm expulsion.
Materials and Methods
Ethics statement
All animal work was approved following local ethical review by
MRC National Institute for Medical Research, NIMR, Animal
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Procedures and Ethics Committee and was performed in strict
accordance with the U. K Home Office Animals (Scientific
Procedures) Act 1986 (approved H.O Project License 80/2506).
Animals and infections
Six to nine week old male and female C57BL/6 and IL-22KO
mice [20] were bred at the specific pathogen-free animal facility at
the MRC National Institute for Medical Research (NIMR,
London, UK). Age- and sex-matched experimental animals (3–8
per group) were infected with 500 infective Nippostrongylus brasiliensis
(Nb) larvae by subcutaneous injection [21] or with 150 embryo-
nated Trichuris muris (Tm) eggs by oral gavage [22].
Cell culture and cytokine analyses
Mesenteric lymph nodes were removed and single cell
preparations were resuspended in RPMI 1640 supplemented with
10% heat-inactivated FCS, 2 mM L-glutamine, 100 U/ml pen-
icillin, 100 mg/ml streptomycin and 0.05 mM b-mercaptoethanol
(Life technologies). Cells were cultured at 37uC and 5% CO2 in
flat-bottomed 96-well plates at a final concentration of 56106/ml
in a final volume of 0.2 ml/well. Cells were stimulated with Nb or
Tm antigen (25 mg/ml), or plate-bound anti-CD3 antibody
(mAb145-2C11, 10 mg/ml, ATCC) and cell-free supernatants
were harvested after 48 hours and stored at 280uC. Cytokine
analyses were carried out using a multiplex cytometric bead assay
(Flowcytomix, eBiosciences). Explants of small intestine were
washed extensively in ice cold PBS and cultured overnight in the
same medium as above, with or without the addition of
recombinant IL-22 (R&D systems). LS174T cells (kindly provided
by Dr AC Williams, University of Bristol, UK) were cultured in
DMEM supplemented with 10% heat-inactivated FCS, 2 mM
L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin.
Lamina propria cell isolation and flow cytometry
After removal of Peyer’s patches the small intestine was cut into
5 mm pieces and epithelial cells and intraepithelial lymphocytes
were first removed by shaking gut pieces in PBS with 10% FCS,
1 mM pyruvate, 20 mM Hepes, 10 mM EDTA, 100 U/ml
penicillin, 100 mg/ml streptomycin, 10 mg/ml Polymyxin B and
2 mM DTT for 30 min at 37 C. The remaining gut tissue was
washed and digested using Collagenase D (Roche, 1 mg/ml) and
DNAse1 (Sigma, 10 U/ml) for 45 minutes at 37uC, before being
subjected to Percoll centrifugation (37.5%), followed by washing
and resuspension of the isolated lamina propria leukocytes in
medium. To identify innate lymphoid cells (ILC), isolated
leukocytes were stained by using fluorochrome-coupled antibodies
against CD45, Thy1.2, IL-7R (CD127) and a combination of
lineage markers (Lin), including CD3, CD8, CD11b, CD11c,
CD19, CD49b, TCR-b, TCR-cd, NK1.1, GR-1 and Ter119. ILC
were defined as CD45+Lin2Thy1.2+IL-7R+. For further charac-
terization of ILC surface marker expression, antibodies against
CD4 and NKp46 were used. For intracellular cytokine staining
isolated leukocytes were restimulated with phorbol 12,13-dibuty-
rate (PdBU) and ionomycin (both at 0.5 mg/ml) in the presence of
brefeldin A (1 mg/ml) for 2.5 h, fixed with formalin (3.8%),
permeabilised with octylphenyl-polyethylene glycol (0.1%, Sigma),
and stained with fluorochrome-coupled antibodies against IL-17A
and IL-22. All samples were acquired on a LSRII flow cytometer
(BD Biosciences) and analysed with the FlowJo software (Treestar
Inc.).
Histopathological analyses
Consecutive lengths of small intestine taken 10 cm distal to the
pyloric sphincter were fixed in neutral-buffered formalin, histo-
logically processed using standard methods, and 5 mm sections
were stained for goblet cells (Periodic Schiff). The number of cells
per 20 randomly selected villus-crypt units (VCU) was determined
under light microscopy from at least two sections per animal.
Real-time PCR
Tissues were harvested and stored in RNAlater (Qiagen) at
280 C until processing. RNA was purified using Trizol (Life
technologies). Reverse transcription was performed using a
Quantitect RT kit (Qiagen) and real time PCR was performed
in an ABI 7500 sequence detection system (Applied Biosystem)
using the SYBR Green PCR Master Mix (Qiagen). Results were
normalised to the housekeeping gene hypoxanthine guanine
phosphoribosyl transferase (HPRT).
Statistical analyses
Significant differences (P,0.05) between experimental groups
were determined using Student’s t-test.
Results and Discussion
N. brasiliensis infection induces IL-22 expression in Th17
cells and innate lymphoid cells in the small intestine
Upregulation of IL-22 expression in the gastrointestinal tract
has been reported in human helminth infection [18,19]. To
address the question if IL-22 may play a role in anti-helminth
immunity, we utilized the mouse model of Nippostrongylus
brasiliensis (Nb). We first assessed IL-22 mRNA expression in the
small intestine at different time points post Nb infection (p.i.)
(Fig. 1A). Elevated expression of Il22 mRNA was found from day
6 p.i. and further increased at day 10 p.i. Flow cytometric
analysis of lamina propria lymphocytes isolated from the small
intestine of infected mice showed IL-22 cytokine staining both in
the lineage-negative (Lin2) and lineage-positive (Lin+) compart-
ments, with the majority (,80%) of the IL-22 coming from Lin+
cells (Fig. 1B, C). Further characterization of the IL-22+Lin+ and
IL-22+Lin2 subsets revealed that amongst the Lin+ cells, CD4+ T
cells were the predominant IL-22+ cell type, while the
IL-22+Lin2 population consisted predominantly of NKp462
Author Summary
Intestinal helminth (worm) infections are some of the most
common parasite infections in the world. Immunity to
worm infection is dependent on the production of Type 2
cytokines, such as IL-4 and IL-13, and the induction of
mucosal defence mechanisms including production of
mucus by intestinal goblet cells. Here we show that the
cytokine IL-22, which was previously known to be involved
in the defence against bacterial infections in the gut, is also
involved in the defence against intestinal worms. IL-22
deficient mice are unable to expel the rodent parasites
Nippostrongylus brasiliensis and Trichuris muris from their
intestines despite the fact that they make strong Type 2
cytokine responses. This inability to expel the worms
correlates with a reduction in the number of goblet cells as
well as a reduction in intestinal mucins and other goblet
cell products. We also demonstrate that IL-22 is able to act
directly on goblet cells to stimulate the secretion of
mediators such as mucins. Taken together, our data show
that IL-22 is a key mediator of anti-helminth immunity in
the gut. Furthermore, our data provide additional insight
into the pivotal role played by IL-22 in protection against
various types of intestinal pathogens.
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innate lymphoid type 3 cells (ILC3) (Fig. 1D, E). Co-staining for
IL-17A demonstrated that ,70% of the T cell-derived IL-22 was
produced by Th17 cells, whereas the majority of the IL-22+Lin2
cells did not show co-production of IL-17A (Fig. 1F). Thus, our
data show that IL-22 is produced by both T cell and non-T cell
populations in the lamina propria during Nb infection. This is in
agreement with a number of studies demonstrating that IL-22
can be produced by a variety of cells in the intestine, including
innate cells, such as LTi, NKp46+ and NKp462 ILC3 cells, as
well as conventional CD4+ T cells [23,24,25]. In addition, Basu
et al [13] recently demonstrated that early production of IL-22
during bacterial infection is mainly derived from innate sources,
shifting to CD4-derived during later stages of infection, and
that both sources play a vital role in protection at different
stages against enteric infection, thus demonstrating the impor-
tance of both innate and adaptive sources of IL-22 in mucosal
responses.
Il222/2 mice show delayed worm expulsion
Although the increased expression of IL-22 in human intestinal
mucosa after helminth infections suggests a possible functional link
between IL-22 and anti-helminth immunity [18,19], the role of
IL-22 in mouse models of gastrointestinal helminth infections has
not been addressed. Therefore, we infected WT and Il222/2 mice
with Nb and assessed the intestinal worm burdens at various time
points after infection (Fig. 2). While similar numbers of parasites
had reached the intestine by day 3 in WT and
Il222/2 mice, indicating an unperturbed lung passage of the Nb
larvae, we observed a marked delay in worm expulsion in Il222/2
mice with significantly increased worm burdens at day 6 and day
10 compared to WT animals (Fig. 2), demonstrating a key role for
IL-22 in the clearance of intestinal helminth infection.
IL-22 is required for goblet cell hyperplasia after Nb
infection
Goblet cell hyperplasia in the intestinal epithelium is a hallmark
of intestinal helminth infections and is crucial for worm expulsion
in Nb infection [26]. Histological analysis of the small intestine of
WT and Il222/2 mice at various time points after Nb infection
revealed a significant reduction of goblet cell numbers in the small
intestine of IL222/2 mice as compared to their WT counterparts
(Fig. 3A, B). Analysis of mRNA expression of the goblet cell
markers Clca3 (Gob5) [27], Retnlb (RELMb), Tff2 (trefoil factor 2)
and mucins Muc1, Muc2 and Muc3 [28], showed that their
upregulation observed in Nb-infected WT mice was almost
completely abolished in absence of IL-22 (Fig. 3C). Thus, the
delayed worm expulsion observed in the absence of IL-22 is
strongly correlated to reduced goblet cell hyperplasia and reduced
expression of goblet cell mediators.
Normal type 2 cytokine production in helminth-infected
Il222/2 mice
Since type 2 responses are instrumental in anti-helminth
immunity and goblet cell hyperplasia, we hypothesized that
impaired type 2 cytokine production may be responsible for the
reduced goblet cell function and delayed worm expulsion in
Il222/2 mice. However, neither type 2 cytokine mRNA expres-
sion in intestinal tissues, or protein levels in supernatants from Nb
antigen-restimulated mesenteric lymph node cells at day 10 p.i.
were impaired in Il222/2 mice (Fig. 4 A, B). In fact, the levels of
IL-4 mRNA in the intestine and IL-5 protein from lymph nodes
were even increased in Il222/2 mice, possibly as a result of
overcompensation due to the increase in worm burden. Therefore,
Il222/2 mice have impaired intestinal worm expulsion and
reduced goblet cell function despite normal type 2 cytokine
production.
Figure 1. IL-22 is produced by both adaptive and innate cells in
the small intestine during N.brasiliensis infection. (A) C57BL/6
mice were infected with N. brasiliensis and RNA was isolated from the
small intestine at various time points. IL-22mRNA expression was
analysed by real-time RT-PCR. Data are pooled from two independent
experiments (n = 3–7 for each time point, and shown as mean of
individual animals+SEM). (B) Representative flow cytometry of leuko-
cytes isolated from the small intestinal lamina propria of infected
C57BL/6 mice after restimulation with PdBU and ionomycin at day 5
post infection. (C) Relative contribution of Lin+ and Lin2 cells to total IL-
22+ cells, analysed as in B. (D, E) Representative flow cytometry and
relative contribution of the different cell subsets in the IL-22+Lin+ (D)
and IL-22+Lin2 compartment (E). Relative contribution of each subset is
expressed as percentage of total IL-22+ cells, analysed as in B. (F)
Representative flow cytometry for IL-22 and IL-17A after restimulation
with PdBU and ionomycin gated on CD4+ T cells (left) and Lin2 cells
(right). Numbers in gates and quadrants represent events in percent of
total cells gated. Each symbol represents one mouse. All data are
representative of two to three independent experiments. *p,0.05,
***p,0.001.
doi:10.1371/journal.ppat.1003698.g001
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IL-22 acts directly on epithelial cells to induce mucin
expression
A possible explanation for the reduction in goblet cell
hyperplasia detected in Il222/2 mice is a direct effect of IL-22
on the differentiation and/or activation status of goblet cells. To
address this possibility, we treated small intestinal tissue ex vivo
from uninfected WT mice with IL-22 and analysed expression of
goblet cell markers. IL-22 treatment induced expression of Retnlb,
Muc1 and Muc3, but not Clca3, Muc2 or Tff2 (Fig. 5A). In addition,
we cultured LS174T cells, a human mucus-secreting intestinal
adenocarcinoma cell line, in the presence of human IL-22, IL-13,
or a combination of both cytokines, and observed that IL-22 alone
induced expression of several mucins including MUC1, MUC3,
MUC4 and MUC5b, but not MUC5AC (Fig. 5B). Similarly to our
observations using mouse tissue (Fig. 5A) we did not observe
induction of expression of Clca1 (the human ortholog of mouse
Clca3) by IL-22, however, IL-13 alone induce expression of Clca1
and this induction was further amplified by IL-22 in a synergistic
manner (Fig. 5B). Taken together, this data demonstrate that
IL-22 alone is able to induce the expression of several goblet cell
mediators whilst also working in synergy with other mucogenic
Figure 2. Il222/2 mice have reduced worm expulsion. Wild-type
(black bars) and Il222/2 (white bars) mice were infected with
N.brasiliensis and worm burden in the small intestine was analysed at
the time points indicated. Data are pooled from three independent
experiments (n = 5–13 for each time point, and shown as mean of
individual animals +SEM). *p,0.05, **p,0.01.
doi:10.1371/journal.ppat.1003698.g002
Figure 3. Il222/2 mice have defective goblet cell responses. Wild-type (black bars) and Il222/2 (white bars) mice were infected with
N.brasiliensis and (A) lengths of jejunum collected on various days post infection, histologically processed, sectioned, stained with Periodic acid schiff
and numbers of goblet cells per twenty randomly selected villus-crypt units determined by light microscopy. (B, C) mRNA expression measured by
realtime RT-PCR in the small intestine of WT (black bars) and Il222/2 (white bars) mice at day 10 post infection, compared to naı¨ve controls. All data
are pooled from three independent experiments (n = 3–7 for each time point and shown as mean of individual animals +SEM). *p,0.05.
doi:10.1371/journal.ppat.1003698.g003
Figure 4. Il222/2 mice have normal Th2 responses. Wild-type
(black bars) and Il222/2 (white bars) mice were infected with
N.brasiliensis and (A) mRNA expression measured by realtime RT-PCR
in the small intestine of WT (black bars) and Il222/2 (white bars) mice at
day 10 post infection, compared to naı¨ve controls. (B) Mesenteric lymph
node cells from Nb-infected WT (black bars) and Il222/2 (white bars)
mice, as well as from uninfected controls of both genotypes (Ctrl), were
removed at day 10 p.i. and stimulated in vitro with Nb antigen.
Supernatants were analysed by sandwich ELISA for the presence of IL-4,
IL-13 and IL-5. All data are pooled from three independent experiments
(n= 3–7 for each time point and shown as mean of individual animals
+SEM). *p,0.05.
doi:10.1371/journal.ppat.1003698.g004
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cytokines such as IL-13, in the induction of other goblet cell
mediators, such as Clca1/3. This data is in agreement with the
study by Sugimoto et al, where IL-22 via STAT3 signaling, was
linked to goblet cell hyperplasia and mucin expression in a model
of colitis [15].
Il222/2 mice have impaired worm expulsion and
defective goblet cell responses to Trichuris muris
infection
In order to confirm the role for IL-22 in anti-helminth immunity
we infected Il222/2 and WT mice with the murine whipworm
Trichuris muris, another helminth model where goblet cells and
mucus production is known to play an important role in resistance
to infection [29,30,31]. We assessed worm burden, cytokine and
goblet cell responses 21 days post infection. Similarly to Nb infection
we found that Tm infected Il222/2 mice had higher worm burdens
despite normal type 2 cytokines responses compared to WT mice
(Fig. 6). Furthermore, Tm infected Il222/2mice had reduced goblet
cell hyperplasia and reduced expression of intestinal Retnlb, Muc1,
Muc3, Clca3 and Tff2, but not Muc2 (Fig. 6). Thus, our data
demonstrate that IL-22 deficiency significantly impairs anti-
helminth immunity and goblet cells function in two different
murine nematode models.
Previous studies have shown that IL-22 is particularly important
in regulating inflammatory responses within the intestine through
the production of antimicrobial peptides, as well as enhancement
and regulation of epithelial wound repair and regenerative
mechanisms [6,10,11,12,13,25]. In addition, IL-22 has also been
shown to play a detrimental role in chronic mucosal inflammation
and progression to colorectal cancer [32,33] demonstrating a
pivotal role for IL-22 in balancing tissue regeneration and tumour
development in the intestinal environment.
Our data now suggest an important function for IL-22 in
promoting other epithelial functions, particularly goblet cell-derived
production of mucins and antimicrobial peptides, leading to anti-
helminth immunity. A previous study by Wilson et al [34] found no
role for IL-22 in the development of hepatic pathology during
infection with the trematode helminth Schistosoma mansoni in mice,
thus supporting the concept that IL-22 exerts organ and/or
pathogen-specific functions. Mucus is believed to play an important
part in intestinal anti-helminth mechanisms, partly through the
generation of the mucus barrier, but also via other proteins in the
secretions such as the antimicrobial peptide Relmb (FIZZ2) which
may impair worm movement and feeding [26,31]. The mucins
themselves are a large family of both secreted and surface bound
glycoproteins, together forming the mucus layer. Quantitative and
qualitative differences in mucus composition are evident during
intestinal infections [35,36] although information is still limited
regarding the contribution of specific mucins to the overall physical
properties of mucus and how mucus composition may change with
respect to different types of infections.
Little is also known regarding the cytokine-mediated control of
mucin expression, but it is clear that a number of cytokines are
able to induce mucin expression, and other goblet cell products in
vitro and in vivo. This includes type 2 cytokines such as IL-13 and
IL-4 [37,38], but also pro-inflammatory cytokines such as TNF
and IL-1 [39,40]. Although IL-13 and IL-4 are believed to be the
key driver cytokines for the induction of goblet cell hyperplasia
during helminth infections [41,42,43], some studies have demon-
strated IL-4/13-independent goblet cell hyperplasia [44]. Further-
more, increase in intestinal Muc2 and Muc3 expression during
infection with the nematode Trichinella spiralis has been reported in
IL-4-deficient mice [45]. The data presented here, together with
that of Sugimoto et al [15], now show that IL-22 is central to
goblet cell hyperplasia and function in the intestine. Our analyses
of Nb and Tm-infected IL-22-deficient mice demonstrate that
IL-22 increases the abundance of goblet cells and is required for
upregulation of mucins and other goblet cell products in vivo. The
Figure 5. IL-22 acts directly on epithelial cells to induce mucin expression. (A) Segments of small intestine from naı¨ve C57Bl/6 mice were
removed, washed in ice cold PBS and incubated at 37 C overnight in complete RPMI medium with or without the addition of 10 ng/ml recombinant
murine IL-22, followed by RNA isolation and analysis by real-time RT-PCR. Data are pooled from two to three independent experiments (n = 4 for each
experiment, data shown as mean of individual animals +SEM). (B) LS174T cells were grown in complete DMEM and incubated with or without 10 ng/
ml recombinant human IL-22, 10 ng/ml recombinant human IL-13, or both, for 24 hours, followed by RNA isolation and analysis by real-time RT-PCR.
Data are pooled from three experiments, error bars represent variation between the independent experiments. *p,0.05.
doi:10.1371/journal.ppat.1003698.g005
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fact that IL-22-deficient mice mount a strong type 2 cytokine
response in both draining lymph nodes and intestinal tissue
provides further evidence that IL-4/13 alone are not sufficient for
promoting effective goblet cell functions during intestinal helminth
infection. In contrast, our ex vivo and in vitro analyses suggest that
IL-22 (and not IL-13) alone might be sufficient to increase mucin
production by the intestinal epithelium in certain settings. In vivo,
however, a concerted action of the type 2 cytokines together with
IL-22, and possibly other inflammatory mediators, is most likely
needed for an efficient anti-helminth response. The reported
findings of upregulated IL-22 expression following human
infections with the whipworm Trichuris trichiuria and the hookworm
Necator americanus [18,19] indicate that IL-22 may play a similar
role in human helminth infections.
In conclusion, our study demonstrates a key role for IL-22 in
goblet cell function and, thus, for anti-helminth immunity in the
intestine. In addition, our data provide additional insight into the
pivotal role played by IL-22 in mucosal immunity in protection
against various types of infectious pathogens.
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